08/06/2025
6:03 AM | Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2025
6:09 AM | Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/30/2025
6:10 AM | Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/02/2025
3:43 PM | Moses Jennifer K. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2025
3:43 PM | Gheuens Sarah (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2025
3:43 PM | Ajer Jeffrey Robert (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2025
3:45 PM | Morris Arlene (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2025
3:46 PM | Kiselak Tomas (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
3:15 PM | Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2025
4:00 PM | Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II GP LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2025
6:16 AM | Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for VRDN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Viridian Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
05/15/2025
10:44 AM | Kynam Capital Management, LP (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
| Form SCHEDULE 13G | |
05/06/2025
6:55 AM | Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2025
6:28 AM | Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2025
6:54 AM | Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
| Form DEF 14A | |
04/25/2025
6:57 AM | Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
| Form DEFA14A | |
04/25/2025
6:59 AM | Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
| Form ARS | |
04/11/2025
4:15 PM | COMMODORE CAPITAL LP (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
| Form SCHEDULE 13G | |
04/09/2025
3:19 PM | Ajer Jeffrey Robert (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/09/2025
3:26 PM | Ajer Jeffrey Robert (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/07/2025
6:12 AM | Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2025
3:27 PM | Tripuraneni Radhika (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/12/2025
3:36 PM | Tripuraneni Radhika (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2025
3:17 PM | CAIN CHRISTOPHER W. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/12/2025
3:19 PM | CAIN CHRISTOPHER W. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
8:12 PM | Harmon Seth (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
8:13 PM | Beetham Thomas W. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
8:14 PM | Mahoney Stephen F. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
8:17 PM | Tousignant Jennifer (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:09 AM | Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
| Form 424B5 | |
03/03/2025
3:35 PM | Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/03/2025
6:33 AM | Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2025
6:11 AM | Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
5:05 PM | Venrock Healthcare Capital Partners III, L.P. (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
12/16/2024
6:22 AM | Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
4:52 PM | Venrock Healthcare Capital Partners III, L.P. (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
4:53 PM | Venrock Opportunities Fund, L.P. (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
3:50 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
3:33 PM | Paradigm Biocapital Advisors LP (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
| Form SC 13G/A | |
11/12/2024
6:15 AM | Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
6:15 AM | Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
An $8 trillion-dollar discovery 17,000 ft underwater (Ad) A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materials critical for AI chips, EV batteries, smartphones, and advanced weapons systems.
While few people know about these metals, global powers—including the U.S., China, and Russia—are racing to secure them. And one tiny public company, recently backed by the U.S. government, holds mining rights to over 340 million tons… and near-monopoly access to the richest zone. See the name and ticker behind America’s $16 trillion resource push. |
10/18/2024
11:33 AM | STATE STREET CORP (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
| Form SC 13G/A | |
09/30/2024
6:12 PM | Beetham Thomas W. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
6:10 PM | Mahoney Stephen F. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
8:00 PM | Fairmount Funds Management LLC (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
| Form SC 13D/A | |
09/17/2024
8:00 PM | Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II GP LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
5:07 AM | Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
| Form 424B5 | |
09/12/2024
4:25 PM | Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2024
3:28 PM | Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
| Form 424B5 | |
09/10/2024
6:11 AM | Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free VRDN Stock Alerts